Soligenix, Inc.

US$0.34As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:SNGXHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (55.34%)
Div yield —
ROE (127.42%)
Biotechnology
Beta (5Y) 2.04
PE TTM —
TSR TTM (78.39%)
Mkt cap US$7.291M
ROIC (84.71%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.351
4.65%
(52.64%)
Hold 1|10|1|9|4
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
0.01
0.01
8.74%
8.57%
24.74%
27.11%
Revenue$M
0.614
0.617
0.641
0.636
7.90%
5.13%
9.82%
3.96%
Peers (US$7.291M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.740
(0.331)
(0.224)
EBIT/Intx
0.831
0.140
0.151
Own earn%
(40.56)
(237.03)
(221.90)
Sh yield%
46.46
28.05
26.52
Owners
Insiders/Inst%
9.59
34.69
Short interest%
4.39
SBC / revenue%
4.25
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
12–19
$1 testx
0.4
Incr. ROIC%
10